Ajanta Hospital And Ivf Centre Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
as on 07-07-2024
- Paid Up Capital ₹ 7.00 M
as on 07-07-2024
- Company Age 20 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 10.67 Cr
as on 07-07-2024
- Satisfied Charges ₹ 11.21 Cr
as on 07-07-2024
- Revenue 9.61%
(FY 2023)
- Profit 61.56%
(FY 2023)
- Ebitda -19.95%
(FY 2023)
- Net Worth 6.36%
(FY 2023)
- Total Assets 2.52%
(FY 2023)
About Ajanta Hospital And Ivf Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 7.00 M.
The company currently has active open charges totaling ₹10.67 Cr. The company has closed loans amounting to ₹11.21 Cr, as per Ministry of Corporate Affairs (MCA) records.
Anil Kumar, Gita Khanna, and Rama Charan serve as directors at the Company.
- CIN/LLPIN
U85110UP2004PTC028464
- Company No.
028464
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Mar 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Uttar Pradesh, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Ajanta Hospital And Ivf Centre?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Kumar  | Managing Director | 31-Mar-2004 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gita Khanna | Whole-Time Director | 31-Mar-2004 | Current |
| Rama Charan | Whole-Time Director | 31-Mar-2004 | Current |
Financial Performance of Ajanta Hospital And Ivf Centre.
Ajanta Hospital And Ivf Centre Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 9.61% increase. The company also saw a substantial improvement in profitability, with a 61.56% increase in profit. The company's net worth moved up by a moderate rise of 6.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ajanta Hospital And Ivf Centre?
In 2023, Ajanta Hospital And Ivf Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Sidbi Creation Date: 14 Sep 2021 | ₹1.00 Cr | Open |
Sidbi Creation Date: 14 Nov 2018 | ₹2.00 Cr | Open |
Hdfc Bank Limited Creation Date: 18 Mar 2018 | ₹7.00 M | Open |
How Many Employees Work at Ajanta Hospital And Ivf Centre?
Unlock and access historical data on people associated with Ajanta Hospital And Ivf Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ajanta Hospital And Ivf Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ajanta Hospital And Ivf Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
